Scott B. Brown, Chief Financial Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 2,500 shares at $2.02 ($5K) on 2022-09-12, disclosed to the SEC on 2022-09-14.
Open-market purchase of $5k TCON by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TCON | BUY | 2021-08-17 | $4K | — | Filing → |
| TCON | BUY | 2021-03-09 | $8K | — | Filing → |